IDenta Corp (OTCMKTS:IDTA) has been trading at a fairly steady share price, since it announced that it had appointed a new CEO, on July 27. The chairman of IDTA, Yaacov Shoham, had announced that the management would be making several structural changes to the company. This also included the appointment of Nash Abramov as the new CEO. The news had little effect on the trading price, which has largely remained unchanged, at $0.0003 per share, until yesterday.
Mr. Abramov brings over 20-years of experience working in the technological-industrial sector, in management positions at different companies. Most of his experience includes transforming family owned businesses through phases of international marketing and industrialization of their products. Moreover, he is also well versed in the acquisition and sale of companies, in the defense and civil sectors. It should be noted here that IDenta is involved in the manufacture of drugs and explosives detection devices.
The company had released a business update for its shareholders, in June, when it announced that the then CEO, Mr. Shoham was invited to showcase the IDTA products to homeland security and federal agencies, in Argentina. The meetings had been arranged by Security Team Network S.A, the local representative of IDenta. Mr. Shoham met with five different agencies and was successful in achieving a high level of satisfaction with the agencies.
The list also included a meeting with the metropolitan police, to whom the company expects to sell a number of its products, through the chief of police. Other notable meetings included representatives of presidential custody, ministry of security, intelligence agencies and PFA Explosives Brigade. The company had also announced that it had to schedule follow-up meetings with some of the attendees, while it was preparing quotes for products, to be mailed to the rest.
IDenta Corp (OTCMKTS:IDTA) lost 33.33% of its share value and closed at a share price of $0.0002, at the end of the August 11 trading session, after having a trade volume of 5.01 million.
Investors Take Note of Progressive Care Inc (OTCMKTS:RXMD) Growth Prospects
Investors have started taking note of Progressive Care Inc (OTCMKTS:RXMD) growth prospects if its performance in the market in the recent past, is anything to go by. Sentiments around the stock have improved in the wake of the company posting impressive monthly sales as it also continues to expand its operations into other states.
Expansion into Pennsylvania and New Jersey is expected to result in new opportunities, as the same will help bolster the company’s target market. Progressive care has also been busy in expanding its warehouse space as part of an effort that seeks to bolster handling capacity.
The healthcare service provider tapping into the debt market to raise money for working capital further underlines how confident it is about its growth prospects going forward. With the new financing, Progressive Care Inc (OTCMKTS:RXMD) should be able to bolster its prospects and handling capacity as it moves to dispense drugs in new markets.
